DK0466174T3 - Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53) - Google Patents

Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)

Info

Publication number: DK0466174T3
Authority: DK; Denmark
Prior art keywords: cnp; physiologically active; hitherto unknown; active pig; peptide
Prior art date: 1990-07-13

Application number

DK91111629.1T

Other languages

Danish (da)

English (en)

Inventor

Hisayuki Matsuo

Kenji Kangawa

Naoto Minamino

Original Assignee

Hisayuki Matsuo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-13

Filing date

1991-07-12

Publication date

1998-01-12

1991-07-12 Application filed by Hisayuki Matsuo filed Critical Hisayuki Matsuo

1998-01-12 Application granted granted Critical

1998-01-12 Publication of DK0466174T3 publication Critical patent/DK0466174T3/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000012421 C-Type Natriuretic Peptide Human genes 0.000 title 1
101800000060 C-type natriuretic peptide Proteins 0.000 title 1
101800000433 CNP-53 Proteins 0.000 title 1
UHSBKBYWHCBDCJ-DYGWFTAGSA-N natriuretic peptide, c-type Chemical compound N1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)CSSC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CC1=CC=CC=C1 UHSBKBYWHCBDCJ-DYGWFTAGSA-N 0.000 title 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
125000000539 amino acid group Chemical group 0.000 abstract 1
239000002934 diuretic Substances 0.000 abstract 1
230000001077 hypotensive effect Effects 0.000 abstract 1
230000001452 natriuretic effect Effects 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Cardiology (AREA)
Immunology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK91111629.1T 1990-07-13 1991-07-12 Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53) DK0466174T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2186582A JP2930380B2 (ja)	1990-07-13	1990-07-13	ブタ由来新規生理活性ペプチド（ｃｎｐ―５３）

Publications (1)

Publication Number	Publication Date
DK0466174T3 true DK0466174T3 (da)	1998-01-12

Family

ID=16191066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91111629.1T DK0466174T3 (da)	1990-07-13	1991-07-12	Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)

Country Status (8)

Country	Link
US (1)	US5340920A (es)
EP (1)	EP0466174B1 (es)
JP (1)	JP2930380B2 (es)
AT (1)	ATE154641T1 (es)
DE (1)	DE69126568T2 (es)
DK (1)	DK0466174T3 (es)
ES (1)	ES2104635T3 (es)
GR (1)	GR3024581T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1118329A4 (en) *	1998-09-28	2004-12-15	Santen Pharmaceutical Co Ltd	LACRYMAL SECRETION PROMOTERS OR OPHTHALMOLOGICAL DROPS CONTAINING NATRIURETIC PEPTIDES AS ACTIVE INGREDIENTS FOR TREATING KERATOCONJUNCTIVITY
BRPI0203172B8 (pt)	2001-09-28	2021-05-25	Nakao Kazuwa	composição farmacêutica para acondroplasia
CN1960758B (zh) *	2004-03-31	2014-10-22	中外制药株式会社	关节炎的治疗剂或预防剂
CN1960757A (zh)	2004-03-31	2007-05-09	中尾一和	身高增加用组合物
DK2348114T3 (en)	2004-04-21	2018-09-03	Alexion Pharma Inc	BONE DELIVERY CONJUGATES AND PROCEDURE TO USE IT FOR TARGETING PROTEINS AGAINST BONE
AU2008326327A1 (en)	2007-11-21	2009-05-28	Biomarin Pharmaceutical Inc.	Variants of C-type natriuretic peptide
DK2432489T3 (en)	2009-05-20	2017-01-16	Biomarin Pharm Inc	VARIETIES OF C-TYPE NATRIURETIC PEPTID
AU2011350066A1 (en)	2010-12-27	2013-07-11	Alexion Pharma International Sarl	Compositions comprising natriuretic peptides and methods of use thereof
WO2013058833A1 (en)	2011-10-19	2013-04-25	Enobia Canada Limited Partnership	Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10052366B2 (en)	2012-05-21	2018-08-21	Alexion Pharmaceuticsl, Inc.	Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en)	2014-07-11	2016-01-14	The Regents Of The University Of Michigan	Compositions and methods for treating craniosynostosis
EP3226891A1 (en)	2014-12-05	2017-10-11	Alexion Pharmaceuticals, Inc.	Treating seizure with recombinant alkaline phosphatase
EP3250227A2 (en)	2015-01-28	2017-12-06	Alexion Pharmaceuticals, Inc.	Methods of treating a subject with an alkaline phosphatase deficiency
EP3337894A1 (en)	2015-08-17	2018-06-27	Alexion Pharmaceuticals, Inc.	Manufacturing of alkaline phosphatases
WO2017058822A1 (en)	2015-09-28	2017-04-06	Alexion Pharmaceuticals, Inc.	Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
JP2018533571A (ja)	2015-10-30	2018-11-15	アレクシオンファーマシューティカルズ，インコーポレイテッド	患者の頭蓋縫合早期癒合症を治療するための方法
US11065306B2 (en)	2016-03-08	2021-07-20	Alexion Pharmaceuticals, Inc.	Methods for treating hypophosphatasia in children
EP3436020A4 (en)	2016-04-01	2019-12-25	Alexion Pharmaceuticals, Inc.	METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
WO2017173413A1 (en)	2016-04-01	2017-10-05	Alexion Pharmaceuticals, Inc.	Treating muscle weakness with alkaline phosphatases
US10988744B2 (en)	2016-06-06	2021-04-27	Alexion Pharmaceuticals, Inc.	Method of producing alkaline phosphatase
JP7018933B2 (ja)	2016-08-18	2022-02-14	アレクシオンファーマシューティカルズ，インコーポレイテッド	気管気管支軟化症の治療方法
CA3057502A1 (en)	2017-03-31	2018-10-04	Alexion Pharmaceuticals, Inc.	Methods for treating hypophosphatasia (hpp) in adults and adolescents
JP2021519590A (ja)	2018-03-30	2021-08-12	アレクシオンファーマシューティカルズ，インコーポレイテッド	糖タンパク質の製造
WO2022173987A1 (en)	2021-02-12	2022-08-18	Alexion Pharmaceuticals, Inc.	Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2544929B2 (ja) *	1987-06-17	1996-10-16	第一化学薬品株式会社	新規生理活性ペプチド
US5114923A (en) *	1988-05-31	1992-05-19	California Biotechnology Inc.	Recombinant techniques for production of novel natriuretic and vasodilator peptides

1990
- 1990-07-13 JP JP2186582A patent/JP2930380B2/ja not_active Expired - Lifetime
1991
- 1991-07-12 US US07/728,221 patent/US5340920A/en not_active Expired - Lifetime
- 1991-07-12 AT AT91111629T patent/ATE154641T1/de not_active IP Right Cessation
- 1991-07-12 EP EP91111629A patent/EP0466174B1/en not_active Expired - Lifetime
- 1991-07-12 DK DK91111629.1T patent/DK0466174T3/da active
- 1991-07-12 ES ES91111629T patent/ES2104635T3/es not_active Expired - Lifetime
- 1991-07-12 DE DE69126568T patent/DE69126568T2/de not_active Expired - Lifetime
1997
- 1997-08-29 GR GR970402223T patent/GR3024581T3/el unknown

Also Published As

Publication number	Publication date
GR3024581T3 (en)	1997-12-31
DE69126568D1 (de)	1997-07-24
ATE154641T1 (de)	1997-07-15
ES2104635T3 (es)	1997-10-16
JP2930380B2 (ja)	1999-08-03
US5340920A (en)	1994-08-23
DE69126568T2 (de)	1997-11-27
JPH0474198A (ja)	1992-03-09
EP0466174B1 (en)	1997-06-18
EP0466174A1 (en)	1992-01-15

Publication	Publication Date	Title
DK0466174T3 (da)	1998-01-12	Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)
NO167295C (no)	1991-10-23	Fremgangsmaate for fremstilling av et terapeutisk aktivt peptid.
FI894187A0 (fi)	1989-09-05	Pulmonar ytaktivt protein och polypeptid anslutande daertill.
DK1188768T3 (da)	2009-09-21	LHRH-antagonisk-peptider
ATE241011T1 (de)	2003-06-15	Serin-reiche peptidlinker
DK0475394T3 (da)	1997-07-07	Rotte C-type natriuretisk peptid cDNA, og precursorprotein
DK0466175T3 (da)	1998-09-07	Porcint CNP-gen og præcursor-protein
BG97123A (bg)	1993-12-24	Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE3751398D1 (de)	1995-08-17	Substrat-Peptide.
SE7712634L (sv)	1978-05-12	Ny polypeptid med serumkalciumreducerande aktivitet
SE8702520D0 (sv)	1987-06-16	Mammal intestine hormone precursor
DK0490383T3 (da)	1997-02-17	Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
EP0687685A4 (en)	1998-07-01	PHYSIOLOGICALLY ACTIVE PEPTIDES
EP0441763A3 (en)	1992-01-15	Heparin-binding growth factor
EP1213297A4 (en)	2004-09-08	NOVEL TACHYKININ PEPTIDES, THEIR PRECURSOR PEPTIDES AND GENES ENCODING THEM
SE9603461D0 (sv)	1996-09-23	New compounds
ATE75486T1 (de)	1992-05-15	Anorexigenische und hypotensive peptide.
JPS53132539A (en)	1978-11-18	Protected amino acid or peptide having said protected amino acid residue
ATE416781T1 (de)	2008-12-15	Antigene modifikation von polypeptiden
DK53290A (da)	1990-03-01	Syntetiske gaer-leader-peptider